myMeso » Veglin http://www.mymeso.org Mesothelioma Blog Mon, 10 Oct 2011 15:27:16 +0000 en hourly 1 http://wordpress.org/?v=3.1.2 MESORFA supports Veglin trials http://www.mymeso.org/2008/03/18/mesorfa-supports-veglin-trials/ http://www.mymeso.org/2008/03/18/mesorfa-supports-veglin-trials/#comments Tue, 18 Mar 2008 21:22:56 +0000 Wendi Lewis http://www.mymeso.org/2008/03/18/mesorfa-supports-veglin-trials/ SOURCE: myMeso › MESORFA supports Veglin trials

]]> mesorfa logo.thumbnail MESORFA supports Veglin trialsThe Mesothelioma Research Foundation of America is supporting of Veglin, a relatively new anti-angiogenesis drug designed to halt blood vessel formation. Anti-angiogenesis drugs target the body’s natural production of Vascular Endothelial Growth Factors (VEGF), proteins that spark blood vessel growth into cancerous tumors and lead to malignancy. is among the cancers being studied in the .

Veglin is undergoing at the University of Southern ’s Keck School of Medicine, and, in August 2007, MESORFA teamed up with doctors at the Yale Cancer Medical Center in an endeavor to meet the needs of the patients on the East Coast.

Veglin inhibits VEGF proteins, halting the formation of blood vessels and limiting the ability of tumors to grow and spread. Veglin is an antisense oligonucleotide, meaning that it can bond to messenger RNA (nucleic acid that directs protein production) and block the production of VEGF proteins.

Trials are targeting patients that have already undergone , and also newly diagnosed patients.

To determine if you qualify for Veglin, please contact Jennifer Paul, Executive Director, by calling 1-800-909-MESO (6376).

SOURCE: myMeso › MESORFA supports Veglin trials

]]> http://www.mymeso.org/2008/03/18/mesorfa-supports-veglin-trials/feed/ 0 MESORFA supports Veglin trials